论文部分内容阅读
慢性肾功能衰竭患者继发甲状旁腺机能亢进时引起的肾性骨营养不良是慢性血液透析(简称血透)尚未解决的主要问题之一,本文报告用心得安治疗以降低其甲状旁腺激素(PTH)水平的研究结果。受试对象均未罹患肝炎,平均年龄为51.2±11.2岁,分为心得安治疗组和单给血透治疗的对照组。依据用药时间和血透时间长短,又将这两大组再分为短程心得安治疗组(P 组),共16例,用心得安时间达6～8月;长程心得安治疗组(Pc 组),有9例,此组患者在受试前曾因高血压或心绞痛用过心得安;开始血透对照组(C_1组)5例,血透时间为0.5个
Renal osteodystrophy due to secondary hyperparathyroidism in patients with chronic renal failure is one of the major unresolved problems of chronic hemodialysis (referred to as hemodialysis), this article reports the use of propranolol to reduce its parathyroid hormone (PTH) level of the results of the study. Subjects were not suffering from hepatitis, with an average age of 51.2 ± 11.2 years, divided into propranolol treatment group and a single hemodialysis treatment control group. According to the time of treatment and the duration of hemodialysis, the two groups were subdivided into short-course treatment group (group P), 16 cases in total. ), There are 9 cases in this group before the test had hypertension or angina pectoris; starting hemodialysis control group (C_1 group) in 5 cases, hemodialysis time was 0.5